Literature DB >> 6368735

Natural resistance of lethally irradiated F1 hybrid mice to parental marrow grafts is a function of H-2/Hh-restricted effectors.

J P Daley, I Nakamura.   

Abstract

The natural resistance of F1 hybrid mice against parental bone marrow grafts is thought to be mediated by natural killer (NK)-like effector cells. However, unlike the NK cell activity against a wide range of tumors and normal cells, hybrid resistance is characterized by the immunogenetic specificity controlled by a set of unique noncodominant genes denoted as Hh. Two alternative hypotheses can account for the specificity. Thus, the specificity may reflect either the Hh restriction of effectors or the Hh gene control of mechanisms regulating non-Hh-restricted effector activity. In this study, therefore, we tested the recognition specificity of putative effectors mediating hybrid resistance in lethally irradiated H-2b/d and H-2b/k F1 hybrid mice to the engraftment of parental H-2b bone marrow. As a direct means of defining the effector specificity, rejection of parental bone marrow grafts was subjected to competitive inhibition in situ by irradiated tumor cells. Of the 16 independent lines of lymphoma and other hemopoietic tumor cells tested, the ability to inhibit hybrid resistance was the exclusive property of all tumors derived from mice homozygous for the H-2Db region, regardless of whether the tumor cells were susceptible or resistant to NK cell-mediated cytotoxicity in vitro. Four cell lines heterozygous for the H-2Db were noninhibitory, including one that is susceptible to natural killing. Pretreatment of the F1 hosts with an interferon inducer augmented the resistance with no alteration in the recognition specificity of effector cells. Therefore, natural resistance to parental H-2b bone marrow grafts was mediated by effectors restricted by the H-2Db/Hh-1b gene(s), and not by the nonrestricted NK cells detectable in conventional in vitro assays.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368735      PMCID: PMC2187270          DOI: 10.1084/jem.159.4.1132

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  DEOXYRIBONUCLEIC ACID METABOLISM IN VIVO: I. CELL PROLIFERATION AND DEATH AS MEASURED BY INCORPORATION AND ELIMINATION OF IODODEOXYURIDINE.

Authors:  W L HUGHES; S L COMMERFORD; D GITLIN; R C KRUEGER; B SCHULTZE; V SHAH; P REILLY
Journal:  Fed Proc       Date:  1964 May-Jun

2.  Histocompatibility genes of the mouse. II. Production and analysis of isogenic resistant lines.

Authors:  G D SNELL; R B JACKSON
Journal:  J Natl Cancer Inst       Date:  1958-11       Impact factor: 13.506

3.  One-hundred-ten patients with aplastic anemia (AA) treated by marrow transplantation in Seattle.

Authors:  R Storb; E D Thomas; P L Weiden; C D Buckner; R A Clift; A Fefer; B W Goodell; F L Johnson; P E Neiman; J E Sanders; J Singer
Journal:  Transplant Proc       Date:  1978-03       Impact factor: 1.066

4.  Engraftment of allogeneic dog bone marrow.

Authors:  H M Vriesendorp; C Zurcher; D W van Bekkum
Journal:  Transplant Proc       Date:  1975-12       Impact factor: 1.066

5.  Inhibitory effect of interferon preparations and inducers on the multiplication of transplanted allogeneic spleen cells and syngeneic bone marrow cells.

Authors:  J C Cerottini; K T Brunner; P Lindahl; I Gresser
Journal:  Nat New Biol       Date:  1973-04-04

6.  Genetics of the murine hemopoietic-histocompatibility system: an overview.

Authors:  G Cudkowicz; I Nakamura
Journal:  Transplant Proc       Date:  1983-12       Impact factor: 1.066

7.  Natural cell-mediated cytotoxicity in rats. II. In vivo augmentation of NK-cell activity.

Authors:  J R Oehler; L R Lindsay; M E Nunn; H T Holden; R B Herberman
Journal:  Int J Cancer       Date:  1978-02-15       Impact factor: 7.396

8.  Recognition and regulation of progenitor marrow elements by NK cells in the mouse.

Authors:  T O'Brien; J Kendra; H Stephens; R Knight; A J Barrett
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

9.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

10.  Reversible induction of natural killer cell activity in cloned murine cytotoxic T lymphocytes.

Authors:  C G Brooks
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

View more
  17 in total

1.  Evidence for differentiation of NK1+ cells into cytotoxic T cells during acute rejection of allogeneic bone marrow grafts.

Authors:  G Dennert; C Knobloch; S Sugawara; B Yankelevich
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

Review 2.  The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.

Authors:  Frank Cichocki; Michael R Verneris; Sarah Cooley; Veronika Bachanova; Claudio G Brunstein; Bruce R Blazar; John Wagner; Heinrich Schlums; Yenan T Bryceson; Daniel J Weisdorf; Jeffrey S Miller
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

3.  In vivo treatment with an appropriate anti-Thy-1.2 monoclonal antibody abrogates hybrid resistance to Thy-1.1+ virus-immune effector T cells.

Authors:  P C Doherty; J E Allan; W Allan
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

4.  Inhibition of pluripotent hematopoietic stem cells of bone marrow by large granular lymphocytes.

Authors:  T Barlozzari; R B Herberman; C W Reynolds
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  Specific inhibition of natural killer (NK) activity against different alloantigens.

Authors:  S Fossum; A Ager; B Rolstad
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

6.  Genetic control of the target structures recognized in hybrid resistance.

Authors:  J P Daley; J M Wroblewski; S G Kaminsky; I Nakamura
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease.

Authors:  B Glass; L Uharek; W Gassmann; B Focks; H Bolouri; H Loeffler; W Mueller-Ruchholtz
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

8.  A genetic analysis of natural resistance to nonsyngeneic cells: the role of H-2.

Authors:  G A Carlson; B A Taylor; S T Marshall; A H Greenberg
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

9.  Hemopoietic histocompatibility (Hh-1) phenotype and the regulation of its expression.

Authors:  S G Kaminsky; M A Yoshida; V K Milisauskas; I Nakamura
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

10.  Hybrid resistance modulates the inflammatory process induced by lymphocytic choriomeningitis virus-immune T cells.

Authors:  P C Doherty; J E Allan
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.